Back to search

Article

Romidepsin and Tamoxifen Cooperatively Induce Senescence of Pancreatic Cancer Cells Through Downregulation of FOXM1 Expression and Induction of ROS/Lipid Peroxidation

2021-12-08

Abstract excerpt

<title>Abstract</title> <p>Although progress has been made in chemotherapeutic strategies against pancreatic cancer, overall survival has not significantly improved over the past decade. Thus, the development of better therapeutic regimens remains a high priority. Pancreatic cancer cell lines were treated with romidepsin, an inhibitor of histone deacetylase, and tamoxifen, and their effects on cell growth, signal...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
544b0e51-1d59-5179-81a8-2a9f7bca917c
DOI
10.21203/rs.3.rs-1125720/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 8 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Romidepsin and Tamoxifen Cooperatively Induce Senescence of Pancreatic Cancer Cells Through Downregulation of FOXM1 Expression and Induction of ROS/Lipid PeroxidationDOI 10.21203/rs.3.rs-1125720/v1
Select a neighboring publication to make it the new centre.